Apoptosis

Scientists Detail Key Molecular Pathway and Potential Drug Targets Against Cancer, Neurodegenerative Disease

Published in Cancer Weekly, March 20th, 2001

Molecular geneticists at the Kimmel Cancer Center of Jefferson Medical College are uncovering clues to how and why cancer cells grow with abandon, while at the same time, understanding why brain cells die too young in neurodegenerative illnesses such as Alzheimer's and Parkinson's diseases.

Understanding the molecular secrets of apoptosis, or programmed cell suicide, they say, will enable scientists to identify potential drug targets against these diseases.

Reporting the results of a study March 1, 2001, in the journal Nature, Emad Alnemri, PhD, professor of microbiology and immunology at Jefferson Medical College of Thomas Jefferson...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2001-03-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry